flexibility, and lack of ionizing radiation, published sonographically guided PSTJ techniques are not without limitations. 5, 10, 18, 19 The posteromedial approach requires needle passage in close proximity to the tibial neurovascular bundle. 5 The posterolateral approach may be technically challenging due to the ergonomics of targeting the deeply located posterior PSTJ recess and may result in inadvertent puncture of the flexor hallucis longus tendon sheath. 5 Although the anterolateral approach targeting the lateral PSTJ recess was preferred by the authors of the previous study and has been successful in clinical practice, the narrow acoustic window for needle passage may render the described out-of-plane needle approach challenging in some clinical circumstances. 5, 10 It is also noteworthy that prior authors have highlighted the fact that image-guided injections targeting the lateral PSTJ recess may be impeded by congenital (eg, fibular overhang), degenerative (eg, osteophytes and narrowing) or postsurgical (eg, hardware) changes in this region. 6, 9, 10 The sinus tarsi is a cone-shaped opening in the anterolateral ankle located between the talar neck and anterosuperior calcaneus. 7, 8, 13, [20] [21] [22] The sinus tarsi extends posteromedially, where it transitions into the tarsal canal and eventually exits above the sustentaculum tali. 8, 13 The contents of the sinus tarsi include fibrofatty tissue containing a fine neurovascular network and several ligamentous structures that function to control talocalcaneal motion and stability: the cervical ligament, interosseous talocalcaneal ligament, and medial and intermediate roots of the inferior extensor retinaculum. 7, 8, 13, 20, 23 The sinus tarsi is bordered posteriorly on its calcaneal side by the PSTJ, which is separated from the sinus tarsi by a capsule and in more than 95% of cases a relatively thick (1.4 ± 0.4 mm) anterior capsular ligament. 20 Although the sinus tarsi is typically discussed in the context of sinus tarsi syndrome, subtalar instability, or periarticular ganglion cysts, it also provides potential access to the PSTJ for diagnostic or therapeutic injections. However, to our knowledge, techniques to inject the PSTJ via the sinus tarsi have not been formally described.
The primary purpose of this investigation was to describe and validate a technique for sonographically guided PSTJ injections performed via the sinus tarsi. On the basis of the known regional anatomy and our preliminary cadaveric and clinical experience, we hypothesized that the PSTJ could be injected with 100% accuracy through the sinus tarsi, as demonstrated in a cadaveric model. Validating the sonographically guided PSTJ injection technique via the sinus tarsi approach would have 2 important clinical implications: (1) provide an alternative route for accurate PSTJ injections when more traditional PSTJ injection approaches are either not feasible or undesirable; and (2) provide the opportunity for combined PSTJ and sinus tarsi injections using a single needle when clinically indicated.
Materials and Methods

General Design
The study consisted of 2 parts, a sonographic component and a CT component. For the sonographic component, the primary investigator (J.S.) performed sonographically guided PSTJ injections via the sinus tarsi approach on 10 unembalmed cadaveric ankle-foot specimens while monitoring PSTJ recess distension sonographically. All 10 injections were completed in the Mayo Clinic Procedural Skills Laboratory, and the primary investigator had more than 8 years of experience in diagnostic and interventional musculoskeletal sonography at the time of the investigation. For the second part of the study, 2 additional specimens were injected in the Mayo Clinic Opus Imaging Research Facility, where CT scanning was available. On the first specimen, the primary investigator performed a single sonographically guided PSTJ injection via the sinus tarsi using a diluted iodinated contrast agent. On the second, a study coinvestigator (N.S.M.), a board-certified, musculoskeletal fellowship-trained radiologist with experience in CT-guided ankle-foot injections, performed a CT-guided PSTJ contrast agent injection from a lateral approach. 16 Contrast flow patterns were assessed with CT. All anatomic specimens for both parts of the investigation were obtained through the Department of Anatomy's Mayo Foundation Bequest Program, were fully thawed at room temperature immediately before use, and were free of signs of surgery, trauma, or major deformity around the foot and ankle region. This research was approved by the Mayo Clinic's Bio-Specimens Subcommittee of the Institutional Review Board.
Anatomic Specimens
A total of 12 unembalmed cadaveric ankle-foot specimens were used for this investigation. Age, sex, body mass index (BMI), and side (left, right, or both) were recorded for each donor. Specimens were obtained on the basis of availability and therefore were not necessarily paired (ie, left and right ankle-foot specimens from the same donor). In addition, no specific measures were taken to ensure an equal number of left and right ankle-foot specimens.
Equipment
The 10 primary sonographically guided PSTJ injections performed in the Procedural Skills Laboratory were completed using an iU22 ultrasound machine and a 17-5-MHz linear array transducer (Philips Healthcare, Bothell, WA). The sonographically guided PSTJ injection performed for CT validation was completed using a CX50 portable ultrasound machine and a 12-3-MHz linear array transducer (Philips Healthcare). The CT-guided PSTJ injection and the CT scans after both the sonographically guided and CT-guided injections were performed using a Sensation 64 scanner (GE Healthcare, Waukesha, WI) with the following parameters: collimation, 12 × 0.3 mm; pitch, 0.8; reconstruction slice and increment, 0.4 to 0.6 and 0.2 to 0.6 mm; tube voltage, 140 kV (peak); and tube current, 250 mA. All injections were performed using 25-gauge, 38-or 50-mm stainless steel needles.
Sonographically Guided PSTJ Injections via the Sinus Tarsi
The primary investigator (J.S.) completed all sonographically guided PSTJ injections during this investigation. Although traditional sinus tarsi injections direct the needle parallel to the sinus tarsi and tarsal canal, from anterolateral to posteromedial, a preliminary investigation determined that this trajectory was not reliable for PSTJ access. 4, 21 An anterior-to-posterior trajectory maintaining the needle parallel and superjacent to the calcaneus was subsequently determined to optimally direct the needle through the anterior aspect of the PSTJ and was therefore used for this study ( Figure 1) .
The procedure for the sonographically guided PSTJ injection via the sinus tarsi is shown in Figure 2 . To perform the PSTJ injection, the ankle-foot specimen was first placed in a relaxed position of plantar flexion and inversion. The posterior PSTJ recess, lateral PSTJ recess, and peroneal tendon sheath were imaged using light transducer pressure to document any baseline fluid. Thereafter, the sinus tarsi was either directly palpated or identified by scanning proximally from the third intermetatarsal space, as previously described. 21 In either case, the bony calcaneal and talar margins were visualized with the transducer in a coronal oblique plane at the level of the sinus tarsi. Thereafter, the transducer was repositioned and the image adjusted to provide the best view of the sinus tarsi's depth and its lateral calcaneal margin. The presence of any baseline fluid was recorded. A 25-gauge, 50-mm stainless steel needle attached to a 12-mL syringe was then advanced using an out-of-plane, anterior-to-posterior approach into the sinus tarsi. The needle trajectory was chosen to pass the needle just superficial and parallel to the superior aspect of the calcaneus. Once the needle advanced to the depth, the tip often became challenging to visualize. Although tip visualization could be obtained via fine transducer manipulation in the out-of-plane view or by switching to an in-plane view, it was deemed unnecessary, as bone contact typically occurred as needle tip visualization deteriorated. At this point, the needle tip was directed through the anterior capsule of the PSTJ, and the capsular penetration was generally easily perceived.
Once the needle penetrated the anterior PSTJ capsule, 2 mL of normal tap water was injected under low pressure, followed by rescanning of the recesses, sinus tarsi, and peroneal tendon sheath using light transducer pressure. The presence of any fluid-induced distension was assessed qualitatively by visually determining whether the recess had enlarged relative to baseline. Thereafter, without changing the needle position, an additional 2 mL of normal tap water were injected (for a total of 4 mL). At this point, the recesses, sinus tarsi, and peroneal tendon sheath were rescanned and results recorded. In addition, distension of the middle facet of the anterior subtalar joint (ASTJ) was sonographically assessed as a control. The ASTJ, also known as the talocalcaneonavicular joint, is separated from the PSTJ by the sinus tarsi and tarsal canal (Figure 1 ). Although the ASTJ, sinus tarsi contents, and PSTJ combine to form the subtalar or talocalcaneal joint complex, the ASTJ is anatomically distinct from the PSTJ; therefore, injectate placed into the PSTJ would not be expected to appear in the ASTJ.
Computed Tomographic Assessment of PSTJ Injection
For the CT portion of the investigation, 2 additional cadaveric specimens were used. In the first specimen, the primary investigator (J.S.) completed a sonographically guided PSTJ injection using the technique described above combined with extension tubing to inject 20% diluted iohexol (Omnipaque 300; GE Healthcare) into the PSTJ. Computed tomographic scanning was performed before injection and after 2-and 4-mL total volume injections. 
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The purpose of these injections was to show via CT arthrography that the PSTJ injection via the sinus tarsi produces a typical PSTJ CT arthrogram. In the second specimen, an experienced study coinvestigator (N.S.M.) completed a single CT-guided PSTJ injection in an additional specimen using a lateral approach, as described by Saifuddin and colleagues. 16 The hindfoot was placed with the medial side down on the CT scanner table and the plantar surface of the foot positioned parallel to the side of the scanner table. A preliminary scan was taken through the hindfoot with an overlying skin marker to precisely identify the lateral opening of the PSTJ. The CT scanner table was brought to the exact position where the PSTJ was best seen in the CT images and marked on the skin surface using the laser crossbeam. A 25-gauge, 38-mm stainless steel needle was then advanced into the lateral aspect of the PSTJ using CT guidance. Once the needle position was confirmed, a 12-mL syringe with short extension tubing containing a 20% dilution of Omnipaque 300 was injected into the PSTJ at 2-mL increments until a total volume of 6 mL had been injected. Although the average volume of the native PSTJ has been estimated to range from 3 to 5 mL, we intentionally completed a 6-mL total volume injection to maximally distend all recesses in this single specimen. 8, 9, 13 During the injection sequence, as was the case for the sonographically guided PSTJ contrast agent injection, CT images were obtained to document contrast flow after each 2-mL incremental injection. The purpose of this injection was to prove that the PSTJ CT arthrogram obtained using a well-accepted CT-guided approach is similar to that obtained using the sonographically guided sinus tarsi approach.
Assessment
The accuracy of the 10 primary sonographically guided PSTJ injections completed by the primary investigator in the Procedural Skills Laboratory was assessed by sonographic documentation of distension of the posterior and lateral PSTJ recesses. Posterior and lateral PSTJ recess distension was documented at baseline and after the 2-and 4-mL total volume injections. In addition, the presence of fluid in the peroneal tendon sheath and sinus tarsi was determined for each condition. Finally, the presence of fluid within the middle facet of the ASTJ was assessed after the 4-mL total volume injection.
The sonographically guided and CT-guided PSTJ contrast agent injections performed in the Opus Imaging Research Facility were assessed by the coinvestigator for contrast flow within the PSTJ, distension of the posterior and lateral PSTJ recesses, contrast flow within the sinus tarsi (ie, distension of the anterior recess), and contrast flow to regions outside the PSTJ. Assessment was performed for both the sonographically guided and CTguided PSTJ injections at baseline and after the 2-and 4-mL total volume injections and again after the 6-mL total volume CT-guided injection.
Statistics
Descriptive statistical analyses were performed to describe donor age, sex, and BMI for all specimens used during the investigation. For the 10 primary sonographically guided PSTJ injections performed via the sinus tarsi approach, descriptive statistics were used to describe: (1) PSTJ accuracy as determined by distension of the posterior and lateral PSTJ recesses; (2) the frequency of posterior and lateral PSTJ recess distension after the 2-and 4-mL total volume injections; (3) the frequency of peroneal tendon sheath fluid after the 2-and 4-mL total volume injections; (4) the frequency of fluid within the sinus tarsi after the 2-and 4-mL total volume injections; and (5) the frequency of fluid within the middle facet of the ASTJ after the 4-mL total volume injection.
For the sonographically guided and CT-guided PSTJ contrast agent injections, CT images were interpreted at each incremental injection volume to assess injection accuracy, as determined by the appearance of a typical PSTJ arthrogram. In addition, posterior PSTJ recess distension, lateral PSTJ recess distension, and the presence of contrast in the peroneal tendon sheath were assessed after the 2-and 4-mL total volume injections. A final assessment of contrast flow was completed on the specimen receiving a CT-guided injection after the 6-mL total volume injection.
Results
A total of 10 sonographically guided PSTJ tap water injections via the sinus tarsi were completed on 10 unembalmed cadaveric ankle-foot specimens (6 right and 4 left) obtained from 6 male donors with a mean age of 81.7 years (range, 72-92 years) and an average BMI of 25.7 kg/m 2 (range, 15.7-38.4 kg/m 2 ). Preinjection scanning showed no appreciable fluid within the PSTJ recesses, sinus tarsi, peroneal tendon sheath, or middle facet of the ASTJ. No technical limitations were encountered during these injections. All 10 PSTJ injections were accurate, as demonstrated by distension of both the posterior and lateral PSTJ recesses after the 4-mL total volume injection. All 10 specimens (100%) had also showed unequivocal posterior recess distension by the end of the 2-mL injection, whereas only 2 specimens (20%) showed lateral recess distension at this injection vol-ume ( Figures 3 and 4) . Although no specimen showed fluid in the sinus tarsi at 2 mL, by 4 mL, all 10 specimens (100%) showed fluid emerging from the depth on the calcaneal side of the sinus tarsi and displacing the sinus tarsi contents superficially ( Figure 5) . No fluid was seen in the peroneal tendon sheath or middle facet of the ASTJ in any specimen at any injection volume. In summary, by the time 2 mL had been injected, fluid was visualized in the posterior recess 100% of the time but in the lateral recess only 20% of the time. By the 4-mL total injection volume, both the posterior and lateral recesses were clearly distended in all specimens (the posterior recess being distended to a greater degree in all specimens), and fluid had also appeared in the depth of the sinus tarsi on the calcaneal side in all specimens. No fluid was visualized in the peroneal tendon sheath or middle facet of the ASTJ in any specimen at any volume.
The single sonographically guided PSTJ contrast agent injection via the sinus tarsi approach was completed on a left ankle-foot specimen obtained from a 77-year-old male donor with a BMI of 23.5 kg/m 2 . Preinjection CT scanning showed no appreciable fluid within the PSTJ 6C ). No contrast was seen in the peroneal tendon sheath or ASTJ (middle facet and talonavicular joint, the latter of which was also visualized by CT; Figure 6C ). The single CT-guided PSTJ contrast agent injection via the lateral approach was completed on a right anklefoot specimen obtained from an 84-year-old male donor with a BMI of 26.1 kg/m 2 . Preinjection CT scanning showed no appreciable fluid within the PSTJ recesses, sinus tarsi, peroneal tendon sheath, or middle facet of the ASTJ. No technical limitations were encountered during this injection. The CT findings during this injection matched those of the sonographically guided PSTJ contrast agent injection at both 2 and 4 mL, with the exception of the observation that by 4 mL, contrast was noted in the peroneal tendon sheath ( Figure 7A ). At 6 mL, disruption of the posterior PSTJ recess and anterior capsule of the PSTJ was evident, as shown by irregular contrast flow into the Kager fat pad and sinus tarsi, respectively ( Figure 7B ). Despite the presumed PSTJ capsuloligamentous rupture, no contrast was visualized in the ASTJ (middle facet and talonavicular joint), confirming the previously noted anatomic discontinuity between the ASTJ and PSTJ of the subtalar joint complex ( Figure 7A ).
Discussion
The primary finding of this investigation was that sonographically guided PSTJ injections via the sinus tarsi approach are feasible and can accurately and specifically deliver injectate into the PSTJ, as demonstrated in this Despite the use of light transducer pressure, there is no clear distension (yellow arrow). Only 2 of 10 specimens showed appreciable lateral recess distension at 2 mL, suggesting that the lateral recess is not as sensitive as the posterior recess for detecting PSTJ distension during injection. Bottom is deep/medial; left, cephalad; right, caudad (CAUD); and top, superficial/lateral. CALC indicates calcaneus; PT, peroneal/fibular tendons; and TAL, talus. C, Same specimen after a 4-mL PSTJ injection. Lateral recess distension is clearly visible, as was the case in all 10 specimens at the 4-mL injection volume. Orientation and labels are as in B.
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cadaveric model. Despite the fact that direct sonographic needle visualization within the PSTJ can be challenging using this approach, distension of the posterior PSTJ recess can be used to confirm accurate needle placement. Several technical considerations are worthy of discussion with respect to the sinus tarsi approach to the PSTJ. First, the needle trajectory should be anterior to posterior and pass just superficial and adjacent to the superior surface of the calcaneus. The PSTJ lies on the calcaneal side of the sinus tarsi, and a posteromedial needle trajectory (as used for traditional "sinus tarsi" injection) will be less likely to enter the PSTJ. 4, 21 In addition, keeping the needle close to the superior calcaneal surface reduces the likelihood of the needle hitting the anterior talar facet rather than passing between the talus and calcaneus (Figure 2 , C and D). Second, as previously stated, accurate needle placement can be confirmed by the development of posterior PSTJ recess distension at a 2-mL injection volume (Figures 3, A-D, and 6, A and B) . After observing the sensitivity of posterior recess distension in our first 5 specimens, the primary investigator elected to dynamically monitor the posterior recess during the subsequent 5 injections. In all 5 specimens, posterior recess distension was clearly evident between the 1-and 2-mL injection volumes. It cannot be overemphasized that during this assessment, the operator must use light transducer pressure to increase the ability to visualize the developing posterior recess effusion. Anchoring the caudad end of the transducer on the posterolateral calcaneus and floating the cephalad end over the soft tissues can assist in this regard. Although not examined as part of this investigation, in clinical practice, the anterior recess of the tibiotalar joint should also be assessed for distension when performing PSTJ anesthetic injection for arthrodesis preoperative planning, as the tibiotalar joint communicates with the PSTJ in up to 20% of the population. 8, 24 Determining the complete distribution of an anesthetic injection is important in this scenario to identify the source of pain, as this information can be used to predict the site of a successful arthrodesis. 17 Third, although some operators are challenged by out-of-plane needle approaches, it is our opinion that the relatively large working space of the sinus tarsi provides greater opportunity to identify the needle tip, readjust as necessary, and appropriately track it to the target. The lack of major neurovascular structures within the sinus tarsi may also be reassuring to operators less experienced with out-of-plane injection techniques such as described herein (Figures 1  and 2B ). 21 Nonetheless, in the primary investigator's experience, the sonographically guided PSTJ injection via the sinus tarsi can be performed using an in-plane approach with the transducer positioned in the axial plane at the level of the superior calcaneal surface and directed medially. The needle trajectory is the same as that used for the described out-of-plane approach (Figure 8 ). In our opinion, the choice of using an out-of-plane or in-plane approach for the injection described herein may largely be a matter of practitioner preference and patient-specific factors. Further experience and research pertaining to each approach may provide further clarification in this regard.
Although we did not directly compare the sinus tarsi approach to the previously published sonographically guided PSTJ techniques, accessing the PSTJ through the sinus tarsi provides several potential advantages. The sinus tarsi approach does not place the needle near major neurovascular structures as does the posteromedial approach and may be less likely to be impeded by congenital, posttraumatic, or postoperative anatomic changes than the anterolateral and posterolateral approaches. 5, 10 Furthermore, as most patients with systemic polyarthritis involving the PSTJ will also have synovitis in the sinus tarsi, it may be desirable to access the sinus tarsi and PSTJ with a single needle for patient comfort and procedural efficiency. 25 This consideration may also be the case when treating patients with combined PSTJ pain and sinus tarsi syn- drome or aspirating sinus tarsi ganglion cysts and injecting their joint of origin, which is typically the PSTJ. 13, 21, 25 The use of CT during this investigation validated and reinforced our sonographic findings by allowing us to globally visualize contrast flow patterns after sonographically guided and CT-guided injections. Although executed through different approaches, the sonographically guided and CT-guided PSTJ contrast agent injections produced excellent and equivalent PSTJ arthrograms (Figures 3, C and  D, and 6, A and B) . Furthermore, the CT arthrograms showed a pattern of posterior-greater-than-lateral recess distension that paralleled the distension observed during the sonographically guided PSTJ tap water injections. Finally, CT confirmed the sonographic observation that accurately placed PSTJ injections do not flow into the ASTJ under normal circumstances, confirming that these regions are anatomically distinct. This separation continued even during the 6-mL CT-guided contrast agent injection, which resulted in anterior and posterior PSTJ capsular ruptures (Figures 1, 6C, and 7A) .
There are several potential study limitations that should be considered when interpreting the results of this investigation. First, operators should use appropriate caution when extrapolating our results in a relatively small number of normal cadaveric specimens to clinical populations. Reassuringly, the primary author has used the sinus tarsi approach on several patients with 100% accuracy, as demonstrated by posterior and lateral PSTJ recess distension. Second, a single experienced operator performed all sonographically guided injections during this study. The use of a single operator was intentional to ensure technical consistency. Although the sinus tarsi approach may be more technically challenging for some operators, we believe that accuracy can be ensured by monitoring posterior recess distension, as previously discussed. Third, we did not assess for iatrogenic injury to the sinus tarsi structures as part of this investigation. Both image-guided and nonguided sinus tarsi injections have been performed for many years without reported complications. In our opinion, the sinus tarsi approach to the PSTJ described herein should not offer a different risk profile compared to the palpation-and image-guided sinus tarsi injections that have been performed for decades. Nonetheless, we typically use Doppler imaging during sinus tarsi procedures to avoid large vessels when possible.
In conclusion, sonographically guided PSTJ injections via the sinus tarsi can accurately and specifically deliver injectate into the PSTJ while monitoring injectate flow within the posterior recess. The sinus tarsi approach may be used as an alternative technique for performing sonographically guided PSTJ injections when clinically appropriate. After a 6-mL diluted contrast agent injection, contrast has appeared in the peroneal tendon sheath. However, no contrast is visualized in the middle facet of the ASTJ (yellow arrow) despite the large volume injection. Bottom is caudad/posterior; left, lateral; right, medial; and top, cephalad/anterior. C indicates calcaneus; and Ta, talus. B, Sagittal CT image of same anatomic specimen after the CT-guided 6-mL diluted contrast agent injection into the PSTJ. At 6 mL, there is disruption of the posterior capsule of the PSTJ with contrast extravasation into the Kager fat pad (yellow arrow). In addition, contrast is visualized extending to the surface of the sinus tarsi (top white arrow) and also surrounding the medial root of the inferior extensor retinaculum (bottom white arrow). These findings are suggestive of anterior capsular rupture. Despite the damage to the PSTJ capsule, contrast did not appear in the middle facet of the PSTJ, as shown in A. Bottom is caudad; left, anterior; right, posterior; and top, cephalad. Cb indicates cuboid; and Ti, tibia; other labels are as in B.
A Figure 8 . Setup for the in-plane approach for the PSTJ injection performed via the sinus tarsi. The transducer is placed in an anatomic axial plane parallel and just cephalad to the superior border of the anterior process of the calcaneus. The needle is advanced using an in-plane, anterior-to-posterior approach along a trajectory similar to Figure 2C . Note that the trajectory of the needle is slightly caudad in an anterior-toposterior direction.
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